| scholarly article | Q13442814 |
| P50 | author | Alessio Fasano | Q18686101 |
| Terez Shea-Donohue | Q37067154 | ||
| Christina S Faherty | Q57009963 | ||
| P2093 | author name string | Tao Wu | |
| Carolyn R Morris | |||
| David A Rasko | |||
| Eileen M Barry | |||
| Christen L Grassel | |||
| Jill M Harper | |||
| P2860 | cites work | Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein | Q24315859 |
| Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea | Q24596978 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure | Q30418560 | ||
| MochiView: versatile software for genome browsing and DNA motif analysis | Q33561311 | ||
| Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo | Q33617990 | ||
| Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri | Q34125052 | ||
| Characterization of the promoter, MxiE box and 5' UTR of genes controlled by the activity of the type III secretion apparatus in Shigella flexneri | Q34200118 | ||
| Shigella isolates from the global enteric multicenter study inform vaccine development | Q34202171 | ||
| Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro | Q34224319 | ||
| MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system | Q34316975 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo | Q34482917 | ||
| Two promoters and two translation start sites control the expression of the Shigella flexneri outer membrane protease IcsP. | Q34763354 | ||
| OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence | Q35073836 | ||
| Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection. | Q35159763 | ||
| RNA-seq analysis of the influence of anaerobiosis and FNR on Shigella flexneri | Q35183286 | ||
| Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease | Q35191900 | ||
| Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains | Q35455031 | ||
| Shigella flexneri infection: pathogenesis and vaccine development. | Q35671854 | ||
| Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. | Q36422508 | ||
| Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model | Q36898582 | ||
| Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies | Q37000878 | ||
| Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid | Q37080399 | ||
| Characterization of intracellular growth regulator icgR by utilizing transcriptomics to identify mediators of pathogenesis in Shigella flexneri | Q37123743 | ||
| Spa15 of Shigella flexneri is secreted through the type III secretion system and prevents staurosporine-induced apoptosis. | Q37451172 | ||
| Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen | Q38332702 | ||
| Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri. | Q38608685 | ||
| Dancing to another tune-adhesive moonlighting proteins in bacteria | Q39214532 | ||
| Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium | Q39572832 | ||
| Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells | Q39610195 | ||
| Identification of the cis-acting site involved in activation of promoters regulated by activity of the type III secretion apparatus in Shigella flexneri | Q39680871 | ||
| Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation. | Q39831093 | ||
| Characterisation of Shigella Spa33 and Thermotoga FliM/N reveals a new model for C-ring assembly in T3SS. | Q40194202 | ||
| An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses | Q40198172 | ||
| Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs. | Q40314454 | ||
| Spa13 of Shigella flexneri has a dual role: chaperone escort and export gate-activator switch of the type III secretion system. | Q41392820 | ||
| Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation. | Q42128393 | ||
| The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri | Q42638971 | ||
| Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses | Q44053369 | ||
| Transcriptional adaptation of Shigella flexneri during adherence to epithelial cells | Q46431834 | ||
| The Pseudomonas syringae HrpJ protein controls the secretion of type III translocator proteins and has a virulence role inside plant cells | Q47744378 | ||
| IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. | Q51189374 | ||
| Broad host range plasmids carrying the Escherichia coli lactose and galactose operons | Q68046570 | ||
| Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells | Q73948765 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri | Q81503204 | ||
| P433 | issue | 6 | |
| P921 | main subject | Shigella flexneri | Q1644417 |
| P304 | page(s) | 486-502 | |
| P577 | publication date | 2016-09-22 | |
| P1433 | published in | Gut microbes | Q26841922 |
| P1476 | title | The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1. | |
| P478 | volume | 7 |
| Q30252849 | Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts. |
| Q93001883 | Bacteriophage Therapy Testing Against Shigella flexneri in a Novel Human Intestinal Organoid-Derived Infection Model |
| Q39230762 | How Do the Virulence Factors of Shigella Work Together to Cause Disease? |
Search more.